CVS, Carvana, and Ares Management Rally on S&P 500 Inclusion and Strong Forecasts

CVS Surges on Profit Forecast and Growth Projections

• 📈 CVS shares rose over 3% after the company increased its full-year profit forecast and projected earnings growth for 2026.
• 💡 This positive outlook offers hope amidst a challenging retail environment and ongoing government scrutiny in the healthcare sector.
• 🚀 The company's new CEO, appointed last year, has overseen significant share price increases, with stock up over 70% through Monday's close.
• 🏥 CVS is noted as potentially the last remaining large publicly traded pharmacy company, with its pharmacy segment profit projected to grow 1%.

Carvana Extends Record Rally with S&P 500 Inclusion

• 🚗 Carvana (CVNA) rallied significantly, extending its gains for an 11th consecutive session, matching a record rally from six years ago.
• 🌟 The surge followed the announcement that Carvana will join the S&P 500 Index starting December 22nd.
• 📊 Passive investing and index funds mean automatic investment in Carvana for many, driving up demand.
• 💰 Bank of America raised its price target for Carvana, anticipating well-above-average growth trends.

Ares Management Jumps on S&P 500 News and Credit Market Resilience

• 💹 Ares Management (ARES) surged nearly 10% following the surprise announcement of its inclusion in the S&P 500 before trading opens on December 11th.
• 📰 This inclusion was announced outside the regular quarterly rebalance, highlighting its significance.
• 🏦 Despite recent turmoil in the credit market, Ares' CEO stated that collapses like those seen with First Trust are not significantly impacting their market so far.
• 🌐 The direct lending industry, a $1.7 trillion market, remains a key focus, with private credit chiefs generally positive about the asset class.